Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$901,085
+$152,121 QoQ
Shares Held
3,548
+15.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#3,109
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Point Capital Partners LLC holds $5,958,387 across 7 Drug Manufacturers - General names. JNJ ranks #4 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
7,549 | $1,899,630 | |
| 2 | MRK |
Merck & Co., Inc.
|
7,670 | $985,595 | |
| 3 | AMGN |
Amgen Inc
|
2,701 | $978,086 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
3,548 | $901,085 | |
| 5 | LLY |
ELI LILLY & Co
|
343 | $411,404 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,249 | $410,478 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,458 | $372,109 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $901,085 | 3,548 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $748,964 | 3,064 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $468,327 | 2,263 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $419,605 | 2,263 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $525,918 | 3,443 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $514,435 | 3,102 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $576,166 | 3,984 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $760,871 | 4,695 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $641,350 | 4,388 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $740,645 | 4,682 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $785,580 | 5,012 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $789,808 | 5,071 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $880,069 | 5,317 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $839,325 | 5,415 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,081,274 | 6,121 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $877,079 | 5,369 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $943,643 | 5,316 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $961,649 | 5,426 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $745,865 | 4,360 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $606,432 | 3,755 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $493,890 | 2,998 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $476,286 | 2,898 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $495,432 | 3,148 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $513,338 | 3,448 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $442,703 | 3,148 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $429,319 | 3,274 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||